Age-Specific Profiles of Antibody Responses against Respiratory Syncytial Virus Infection. - Wikidata - awgldk - TriplyDB

Age-Specific Profiles of Antibody Responses against Respiratory Syncytial Virus Infection.

Age-Specific Profiles of Antibody Responses against Respiratory Syncytial Virus Infection.

http://www.wikidata.org/entity/Q33809443

about

IgG3 Snitcher of RSV Infections in the Very Young.On the relative role of different age groups during epidemics associated with respiratory syncytial virus.

P2860

Q40346231-F00570B8-CE36-4BB3-8167-9488BD37FF0F Q45325184-4DF992EB-4E5F-4AF8-A57E-09DC4592A7D5

P2860

Age-Specific Profiles of Antibody Responses against Respiratory Syncytial Virus Infection.

http://www.wikidata.org/entity/Q33809443

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Age-Specific Profiles of Antib ...... ory Syncytial Virus Infection.

@ast

Age-Specific Profiles of Antib ...... ory Syncytial Virus Infection.

@en

type

label

Age-Specific Profiles of Antib ...... ory Syncytial Virus Infection.

@ast

Age-Specific Profiles of Antib ...... ory Syncytial Virus Infection.

@en

prefLabel

Age-Specific Profiles of Antib ...... ory Syncytial Virus Infection.

@ast

Age-Specific Profiles of Antib ...... ory Syncytial Virus Infection.

@en

P1433

Q33809443-429D58CE-F6CD-478F-8656-39D5A3C53E99

P1476

Q33809443-469C5F6A-9EA8-4B68-A112-46E9147B6CEA

P2093

Q33809443-0524A888-05A9-4CBB-95EC-96842AC7B915

Q33809443-096C5306-29A6-4B70-B393-3F5407FB3499

Q33809443-0FC55235-443A-4AC7-8EDC-16DDAACC2E4D

Q33809443-18F1306C-51C1-4AD3-9354-53BBF947FC88

Q33809443-2AAF6C89-0AD6-4FF0-ABE6-D8A6AC28A075

Q33809443-67F697E1-92B7-464D-848B-A37E376B4F0C

Q33809443-7B0C9A28-9199-4667-9BCA-8E8AB3497FC2

Q33809443-95833FEE-0574-4A10-97D1-9E69FFAC3FF4

Q33809443-B76FA69F-575E-4B71-BAE0-41D7E3DC2579

Q33809443-C670E3E1-8383-4D16-A8F6-D84E4A9FE7BD

P2860

Q33809443-161DDBA6-1089-4508-B57E-76A3F66937CD

Q33809443-17C7694B-723D-4020-AD05-9E1A0B6E5E67

Q33809443-1CF5DFB3-F443-4258-957C-9865DB28C67F

Q33809443-1DB5BDC9-7132-4B15-9953-995620F01FFF

Q33809443-26BD7DAE-9B0C-4F0C-997D-6DEA760EBCCA

Q33809443-308D2200-E13A-42F4-8B1E-06641D77B8B1

Q33809443-34B3045C-A1EE-4A4A-9966-E947560FF9DB

Q33809443-439DFC51-63BD-4513-BC89-B69AE4639C58

Q33809443-47AA970E-929B-4B7A-A8C9-6F5C32541998

Q33809443-5D03BA17-B801-4EF5-9A22-9F63B3E101FB

P304

Q33809443-D62FFD1A-D89F-45DB-AF4B-92D5CB9F5B5E

P31

Q33809443-4DAE6579-174E-4432-920C-7BE7F60E4736

P356

Q33809443-46D2F5B3-DDDD-4B49-A05E-83BE953C696C

P478

Q33809443-81A10B66-43EE-45E0-B59D-76EEF8005D53

P50

Q33809443-6AD8AF0E-49FB-4DFE-A8E9-9A411D39FEAC

P577

Q33809443-8FD8C55A-A2F2-4108-A70A-2D63A2767707

P698

Q33809443-90557756-8116-4782-8C12-A0CDE0AACEE8

P932

Q33809443-280167BC-4C45-4DFE-9686-0A448FAB93E8

P356

J.EBIOM.2017.01.014

P1433

P1476

Age-Specific Profiles of Antib ...... ory Syncytial Virus Infection.

@en

P2093

Chiaki Kawakami

http://www.w3.org/2001/XMLSchema#string

Fumihiko Takeshita

http://www.w3.org/2001/XMLSchema#string

Hideyuki Ikematsu

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Shimizu

http://www.w3.org/2001/XMLSchema#string

Katsuyasu Ishida

http://www.w3.org/2001/XMLSchema#string

Kazue Inoue

http://www.w3.org/2001/XMLSchema#string

Kazuki Miyaji

http://www.w3.org/2001/XMLSchema#string

Masaaki Mori

http://www.w3.org/2001/XMLSchema#string

Megumi Yoshioka

http://www.w3.org/2001/XMLSchema#string

Miyuki Tozuka

http://www.w3.org/2001/XMLSchema#string

P2860

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases

Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines.

Immunoglobulin G3 from polyclonal human immunodeficiency virus (HIV) immune globulin is more potent than other subclasses in neutralizing HIV type 1.

Treatment with respiratory syncytial virus G glycoprotein monoclonal antibody or F(ab')2 components mediates reduced pulmonary inflammation in mice

Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group.

Human IgG subclasses: in vitro neutralization of and in vivo protection against West Nile virus.

The burden of respiratory syncytial virus infection in young children

P304

124-135

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EBIOM.2017.01.014

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-01-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28111238

http://www.w3.org/2001/XMLSchema#string

P932

5474434

http://www.w3.org/2001/XMLSchema#string